Suchergebnisse - (Person:"Lu, Yong")

PubPharm (17)

1

MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs

enthalten in: Oncotarget | 2021

von Semaan, L. | Zeng, Q. | Lu, Y. | +6

2

Analysis of the PI3K-AKT-mTOR pathway in penile cancer : evaluation of a therapeutically targetable pathway

enthalten in: Oncotarget | 2018

von Adimonye, A. | Stankiewicz, E. | Kudahetti, S. | +6

3

Sweyjawbu expression is a predictor of ALK rearrangement status in lymphoma

enthalten in: Oncotarget | 2017

von Xue, K. | Ye, X. | Liu, F. | +7

4

Detection of ALK rearrangements in lung cancer patients using a homebrew PCR assay

enthalten in: Oncotarget | 2017

von Yu, H. | Chang, J. | Liu, F. | +8

5

Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor

enthalten in: Oncotarget | 2017

von Cheng, X. | Liu, Y. | Wang, G. | +10

6

Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population

enthalten in: Oncotarget | 2016

von Zhou, F. | Chen, X. | Pu, J. | +6

7

NKAIN2 functions as a novel tumor suppressor in prostate cancer

enthalten in: Oncotarget | 2016

von Mao, X. | Luo, F. | Boyd, L. | +15

8

Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma

enthalten in: Oncotarget | 2016

von Xia, Y. | Yang, L. | Xue, G. | +7

9

MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity

enthalten in: Oncotarget | 2016

von Wang, Y. | Shao, N. | Mao, X. | +16

10

Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo

enthalten in: Oncotarget | 2016

von Yu, X. | Lin, S. | Du, H. | +9